Close
Close
Treatment News

PROMETRIKA to Coordinate Second Phase I Trial for MD Anderson’s Institute for Applied Cancer Science

2.5
2.5 from 2 votes
Wednesday, October 18, 2017

PROMETRIKA, LLC, a boutique full service Clinical Research Organization (CRO), is coordinating a Phase 1 trial for The University of Texas MD Anderson Cancer Center's Institute for Applied Cancer Science. PROMETRIKA is responsible for the clinical trial management and site monitoring, medical monitoring, database implementation and data management, pharmacovigilance, biostatistics, and medical writing for this advanced solid tumors and lymphoma trial.

"We are excited to work on a second Phase I trial with the institution as it works to end cancer," said Miganush Stepanians, Ph.D., President and CEO of PROMETRIKA.

This study presents another opportunity for PROMETRIKA to leverage its considerable expertise and experience in Phase 1 oncology trials and to contribute to the ongoing fight against cancer.

About PROMETRIKA, LLC

www.prometrika.com
Founded in 2003 and based in Cambridge, Massachusetts, PROMETRIKA is a unique Clinical Research Organization, utilizing a collaborative approach to clinical development and execution with a close-knit, highly-experienced senior leadership team that remains involved throughout the duration of each trial. PROMETRIKA's services include complete clinical operations and clinical trial management, data management, pharmacovigilance, biostatistics and programming, medical writing, and regulatory submissions.

Contact:

PROMETRIKA, LLC
Jillian Pammett, 617-844-0240
jpammett@prometrika.com

Source: PROMETRIKA
2.5
2.5 from 2 votes
Free Newsletter
Trending News
Related Videos
by Abidemi Uruejoma
684 views
by Abidemi Uruejoma
758 views
by Abidemi Uruejoma
5,335 views
by Dr. Jules Richard Kemadjou
8,229 views